SCHEMBL8323797

SCHEMBL8323797

[c]1ccc(-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
AGTR1 P30556 1/20 0.37
AGTR2 P50052 1/20 0.37
ALDH1A1 P00352 6/20 0.36
TSHR P16473 4/20 0.36
HTT P42858 2/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PTGS2 P35354 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.34
P2RX7 Q99572 2/20 0.34
MAPK10 P53779 1/20 0.32
HSD11B1 P28845 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
CCR6 P51684 1/20 0.32
CACNA1B Q00975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9383185 0.90 AGTR1 (0.46) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL976147 0.89 LMNA (0.47) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL27347057 0.84 LMNA (0.36) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL9235857 0.83 MEN1 (0.42) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL9025603 0.81 MEN1 (0.41) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL27373084 0.80 AGTR1 (0.41) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL7195878 0.78 LMNA (0.43) LMNAAGTR1AGTR2ALDH1A1HTT
SCHEMBL7196989 0.78 AGTR1 (0.41) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL9025749 0.78 AGTR1 (0.43) LMNAHSD17B10AGTR1AGTR2ALDH1A1
SCHEMBL3256000 0.78 CA1 (0.43) LMNAHSD17B10AGTR1AGTR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0589665-B1 4,5,6,7-Tetrahydro-1H-imidazo 4,5-c pyridine-6-carboxylic acid amide derivatives as angiotensine II antagonistes KUREHA CHEMICAL IND CO LTD (JP) 1999-11-17 EP claimed
EP-0589665-A2 4,5,6,7-Tetrahydro-1H-imidazo 4,5-c pyridine-6-carboxylic acid amide derivatives as angiotensine II antagonistes KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-03-30 EP claimed
CN-102311426-B Preparation method of olmesartan intermediate NINGBO MEINUOHUA PHARMACEUTICAL CO LTD 2013-06-05 CN disclosed
CN-102311426-A Preparation method of olmesartan intermediate NINGBO MEINUOHUA PHARMACEUTICAL CO LTD 2012-01-11 CN disclosed
CN-1115337-C Pyrimidinone derivs. BORYUNG PHARM (KR) 2003-07-23 CN disclosed
EP-0589665-B1 4,5,6,7-Tetrahydro-1H-imidazo 4,5-c pyridine-6-carboxylic acid amide derivatives as angiotensine II antagonistes KUREHA CHEMICAL IND CO LTD (JP) 1999-11-17 EP disclosed
CN-1160395-A Pyrimidone derivatives BORYUNG PHARM (KR) 1997-09-24 CN disclosed
US-5401736-A Angiotensis II antagonists KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1995-03-28 US disclosed
EP-0589665-A2 4,5,6,7-Tetrahydro-1H-imidazo 4,5-c pyridine-6-carboxylic acid amide derivatives as angiotensine II antagonistes KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-03-30 EP disclosed